▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

BriaCell Therapeutics (NASDAQ: BCTX)

$3.49

(0.6%)

$0.02

Price as of June 11, 2025, 4:00 p.m. ET

BriaCell Therapeutics Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
BCTX	-82.64%			-99%
S&P	+12.04%	+98.01%	+14.64%	+203%

BriaCell Therapeutics Company Info

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

News & Analysis

No articles found.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services